Compositions for the treatment of affections of the oral cavity and upper respiratory tract

1. A composition, for the treatment of an affection of the oral cavity and upper respiratory tract, comprising:

1-200 mg anthocyanosides;

1-200 mg procyanidins; and

1-200 mg phloroglucinols,

Wherein the anthocyanosides are derived from a Vaccinium myrtillus extract, the procyanidins are derived from a Vitis vinifera extract, a Camellia sinensis extract or from another edible plant containing the procyanidins, and the phloroglucinols are derived from Hypericum spp., Myrtus spp. or Humulus lupulus extracts.

2. The composition as claimed in claim 1 , wherein the phloroglucinols are derived from Hypericum perforatum or Myrtus communis extracts, or from Humulus lupulus fractions enriched in α and β acids.

3. The composition as claimed in claim 2 , wherein 20-80% of the phloroglucinols from the β acids of Humulus lupulus are colupulone, and the α acids contain 20-80% of humulone.

4. The composition as claimed in claim 3 , wherein 60% of the phloroglucinols from the β acids of Humulus lupulus are colupulone, and the α acids contain 60% of humulone.

5. The composition as claimed in claim 1 , wherein the Hypericum sp extract is a Hypericum perforatum extract with a phloroglucinol content ranging from 20-80%.

6. The composition as claimed in claim 5 , wherein the phloroglucinols content of the Hypericum perforatum extract is 60%.

7. The composition as claimed in claim 2 , wherein the Myrtus communis extract is prepared from leaves of Myrtus communis by extraction with carbon dioxide at a pressure ranging from 235 to 260 bars and a temperature ranging from 40-60° C.

8. The composition as claimed in claim 7 , wherein the Myrtus communis extract has a myrtucommulone content of 35%.

9. The composition as claimed in claim 1 , further containing at least one essential oil.

10. The composition as claimed in claim 9 , wherein the essential oil is mint oil.

11. A method for the treatment of an affection of the oral cavity and upper respiratory tract, said method comprises: administering to a patient in need thereof an effective amount of a medicament containing:

1-200 mg anthocyanosides;

1-200 mg procyanidins; and

1-200 mg phloroglucinols,

Wherein the anthocyanosides are derived from a Vaccinium myrtillus extract, the procyanidins are derived from a Vitis vinifera extract, a Camellia sinensis extract or from another edible plant containing the procyanidins, and the phloroglucinols are derived from Hypericum spp., Myrtus spp. or Humulus lupulus extracts.

12. The method as claimed in claim 11 , wherein the phloroglucinols are derived from Hypericum perforatum or Myrtus communis extracts, or from Humulus lupulus fractions enriched in α and β acids.

13. The method as claimed in claim 12 , wherein 20-80% of the phloroglucinols from the β acids of Humulus lupulus are colupulone, and the α acids contain 20-80% of humulone.

14. The method as claimed in claim 13 , wherein 60% of the phloroglucinols from the β acids of Humulus lupulus are colupulone, and the α acids contain 60% of humulone.

15. The method as claimed in claim 11 , wherein the Hypericum sp extract is a Hypericum perforatum extract with a phloroglucinol content ranging from 20-80%.

16. The method as claimed in claim 15 , wherein the phloroglucinols content of the Hypericum perforatum extract is 60%.

17. The method as claimed in claim 12 , wherein the Myrtus communis extract is prepared from leaves of Myrtus communis by extraction with carbon dioxide at a pressure ranging from 235 to 260 bars and a temperature ranging from 40-60° C.

18. The method as claimed in claim 12 , wherein the Myrtus communis extract has a myrtucommulone content of 35%.